Thermo Fisher Scientific Inc. has announced a collaboration with Dr. Park, an emerging viral vector contract development and manufacturing organisation (CDMO) in South Korea. The company has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility,
FUJIFILM Biotechnologies has officially opened its new manufacturing site in Holly Springs, North Carolina, marking the first phase of a planned $3.2 billion investment. The facility is one of the largest commercial-scale cell culture biomanufacturing sites in North America. The
The Ritedose Corporation has announced a $17 million investment to expand its in-house cGMP laboratory facilities, enhancing both analytical chemistry and microbiology capabilities. The project will add 10,000 square feet of laboratory space and provide advanced analytical services to support
Artificial intelligence (AI) agents could dramatically accelerate clinical drug development, delivering 35 to 45 percent productivity gains across all clinical functions while cutting trial design timelines in half, according to a comprehensive analysis from McKinsey & Company. The consulting firm’s
Hovione and Microinnova Engineering have announced a partnership to advance the development and testing of modular manufacturing equipment for flow chemistry. The collaboration focuses on creating multi-purpose, plug-and-play equipment designed to enhance process development and accelerate the transition from lab-scale
SyVento BioTech has announced a strategic partnership with Kymos Group aimed at delivering comprehensive solutions for RNA-based therapeutics. The collaboration combines SyVento’s preclinical and clinical drug development, liposomal and LNP technologies, and GMP manufacturing expertise with Kymos’ advanced bioanalytical and
SHL Medical has formed a non-exclusive strategic partnership with Lyophilization Technology, Inc. (LTI), a contract development and manufacturing organisation (CDMO) specialising in lyophilisation of healthcare products. The agreement, part of SHL’s alliance partnership framework, will focus on advancing lyophilised injectable
Eli Lilly and Company (Lilly) has announced plans to construct a $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The new site will be dedicated to producing small-molecule active pharmaceutical ingredients, with operations expected to begin within five
NorthStar Medical Radioisotopes, LLC has announced a partnership with the University of Wisconsin School of Medicine and Public Health. The agreement, working with the school’s Initiative for Theranostics and Particle Therapy (ITPT), will support research, clinical development, and workforce training
Catalent, Inc. has officially opened its new global corporate headquarters in Tampa, Florida. The facility is located on the 41st floor of the Bank of America Plaza in the city’s Central Business District. The relocation follows an earlier announcement that
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
